Improved survival in adult ALL
Improved survival in adult ALL
Activated JAK-STAT signaling co-operates with HOXA9 to drive leukaemia
SL401 in patients with rare neoplasm
RNA regulation of JAK-STAT pathways in CML
Pre-leukaemic clones that survive chemo linked to higher risk of AML recurrence
Blinatumomab improves survival in ALL patients
Evaluation of ibrutinib in treatment of CLL with 17p deletion
Nivolumab restores effective anti-tumour response in Hodgkin lymphoma
An overview of MCL from EHA 2016
The value and strategy for incorporating biosimilars Into clinical practice
Checkpoint inhibitor therapy benefits advanced bladder cancer patients
Adjuvant docetaxel fails after radical prostatectomy for high risk prostate cancer